OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone forma…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
This week | ||
RRealtid | ||
Older | ||
RRealtid | ||
RRealtid | ||
EEFN | ||
RRealtid | ||
OssDsign AB (FRA:5J6) Q4 2025 Earnings Call Highlights: Strong Growth Amid Currency Challenges OssDsign AB (FRA:5J6) reports impressive constant currency growth and high gross margins, while outlining strategic priorities to overcome market penetration challenges. | ||
RRealtid | ||
OssDsign (OM:OSSD) Eyes 25.1% Revenue Growth; Premium Valuation Heightens Profitability Focus OssDsign (OM:OSSD) is expected to deliver robust revenue growth of 25.1% per year, far exceeding the Swedish market's projected 3.7% annual growth. Despite this top-line momentum, the company remains unprofitable and has not set expectations for reaching profitability within the next three years. However, it has managed to reduce its losses at a rate of 6.3% per year over the past five years. Investors are focused on this balance of strong growth prospects and steady loss reduction, set... | ||
OssDsign AB (STU:5J6) Q3 2025 Earnings Call Highlights: Record Sales Month and Strategic Growth ... Despite seasonal challenges, OssDsign AB (STU:5J6) reports robust growth, strong margins, and strategic plans to double its US sales force. | ||
OssDsign AB (STU:5J6) Q2 2025 Earnings Call Highlights: Strong Growth and Strategic Expansion Plans OssDsign AB (STU:5J6) reports impressive growth and outlines ambitious plans for market expansion despite facing some challenges. | ||